Back to top
more

MetLife (MET)

(Real Time Quote from BATS)

$80.17 USD

80.17
110,097

+0.92 (1.16%)

Updated Sep 19, 2024 09:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 14% (36 out of 251)

Industry: Insurance - Multi line

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Is MetLife (MET) Outperforming Other Finance Stocks This Year?

by Zacks Equity Research

Here is how MetLife (MET) and Popular (BPOP) have performed compared to their sector so far this year.

Is MetLife (MET) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Analyzing MetLife Stock: Is Buy Strategy the Right Move?

by Zacks Equity Research

MET remains well-poised for growth, attributed to strength in the EMEA segment, divestiture of underperforming businesses and a commendable financial stand.

Are Investors Undervaluing CNO Financial Group (CNO) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are You Looking for a High-Growth Dividend Stock?

by Zacks Equity Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.

Zacks Industry Outlook Highlights MetLife, American International Group, Prudential Financial, Assurant and MGIC Investment

by Zacks Equity Research

MetLife, American International Group, Prudential Financial, Assurant and MGIC Investment are part of the Zacks Industry Outlook article.

Tanuka De headshot

5 Stocks to Watch From the Prospering Multiline Insurance Industry

by Tanuka De

Better pricing, product redesigns, technological advancement, and improving inflation are expected to aid multiline insurers like MET, AIG, PRU, AIZ and MTG.

Sheraz Mian headshot

Top Stock Reports for NVIDIA, AT&T & Lockheed Martin

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), AT&T Inc. (T) and Lockheed Martin Corporation (LMT), as well as two micro-cap stocks Steel Partners Holdings L.P. (SPLP) and Natural Resource Partners L.P. (NRP).

Tanuka De headshot

Prudential Financial Lags Industry: Is the Stock a Hold or Fold?

by Tanuka De

Investors who already have PRU stock in their portfolio should retain it as this insurance behemoth is unlikely to disappoint.

Tanuka De headshot

Hanover Insurance Group Stock Near 52-Week High: Time to Buy?

by Tanuka De

THG stands to gain from growth in the Core Commercial and Specialty segments, stable retention, better pricing, strong market presence and solid capital position.

Tanuka De headshot

Trupanion Stock Near 52-Week High: Time to Buy or Hold?

by Tanuka De

TRUP is poised to grow on its focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position.

Here's Why MetLife (MET) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why MetLife (MET) is a Great Dividend Stock Right Now

by Zacks Equity Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.

Why MetLife (MET) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

MetLife (MET) Q2 Earnings Beat on Favorable Underwriting Results

by Zacks Equity Research

MetLife's (MET) second-quarter 2024 results benefit from improved variable investment income, strong volumes and strength in the Group Benefits segment. However, poor performance in the RIS segment partially offset the results.

Here's What Key Metrics Tell Us About MetLife (MET) Q2 Earnings

by Zacks Equity Research

The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

MetLife (MET) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

MetLife (MET) delivered earnings and revenue surprises of 7.04% and 2.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Kaibalya Pravo Dey headshot

Q2 Beat or Miss: What's Ahead for These 5 Insurance Stocks?

by Kaibalya Pravo Dey

Improving business environment, underwriting practices and other factors are expected to have benefited insurance players in the second quarter. MET, AFL, AIG, ALL and EG will release earnings on Jul 31.

Can MetLife (MET) Tackle Lower Premiums in Q2 Earnings?

by Zacks Equity Research

MetLife's (MET) Q2 results are likely to benefit from growing net investment income and a well-performing Latin America segment, partly offset by a fall in overall premiums.

Stay Ahead of the Game With MetLife (MET) Q2 Earnings: Wall Street's Insights on Key Metrics

by Zacks Equity Research

Get a deeper insight into the potential performance of MetLife (MET) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

MetLife (MET) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

by Zacks Equity Research

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?

MetLife (MET) Arm MIM Secures $1.2B for 2nd Private Equity Fund

by Zacks Equity Research

MetLife (MET) Arm, MIM, plans to utilize $250 million on new private equity opportunities.

MetLife (MET), GeoBlue Unveil Globaline for Expatriate Benefits

by Zacks Equity Research

MetLife (MET) and GeoBlue launch Globaline, a comprehensive expatriate benefits solution, offering unified medical and ancillary coverage, leveraging extensive global health networks for seamless support.

MetLife (MET), Micruity Unite to Enhance Retirement Solutions

by Zacks Equity Research

MetLife (MET) expands collaboration with Micruity in a bid to develop MetLife's Universal Digital Platform and enhance access to retirement solutions.